HOMe-based HEart Failure Self-Management Programme Study (The HOM-HEMP Study)
1 other identifier
interventional
213
1 country
1
Brief Summary
Aim: To develop a nurse-led, home-based self-management psychosocial education programme, entitled HOMe-based HEart Failure Self-Management Programme (HOM-HEMP), and evaluate its effects on improving heart failure self-care, cardiac self-efficacy, health-related quality of life (HRQoL), psychological well-being, perceived social support, and clinical outcomes among patients with heart failure in Singapore. Background: The number of elderly people is expected to increase in the coming decades, and so too the prevalence of with chronic heart failure (HF) is expected to increase. Since HF is a chronic condition, there is a need to develop programmes that will improve the quality of life of older patients who have to manage this condition for years to come. Design: A stratified, three-arm randomised controlled trial (RCT) will be adopted. Methodology: The HOM-HEMP is designed a six-week home-based psychosocial education programme comprising of a specifically developed HF education and self-management toolkit and three biweekly home visits by the research nurse. In addition, participants in experimental group B will receive a supplementary smartphone app. A consecutive sample of 213 patients with HF will be recruited from the cardiac ward of a tertiary public hospital in Singapore. They will be randomly assigned to the control group, or experimental group A (HOM-HEMP without App) or the experimental group B (HOM-HEMP with App). A research nurse will be delivering the HOM-HEMP intervention to the participants in the experimental groups, while another research assistant who is blinded to participants' group assignment will be responsible for data collection. Data will be collected at baseline, at 6 weeks from baseline (i.e. immediate after the intervention), and at 3 and 6 months from the baseline. At the end of the programme, a process evaluation will be conducted to assess the acceptability, strengths and weaknesses of the HOM-HEMP based on the participants' perspectives. Discussion: It is expected the proposed RCT will make a contribution to knowledge development of the effectiveness of the HOM-HEMP and the active ingredients of the programme.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2017
CompletedFirst Posted
Study publicly available on registry
April 11, 2017
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedMarch 15, 2021
March 1, 2021
1.7 years
March 30, 2017
March 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HF self care
As measured by the Self-Care Heart Failure Index (SCHFI)
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Secondary Outcomes (4)
Cardiac Self-Efficacy
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Anxiety and depression levels
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Health-related quality of life (HRQoL)
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Perceived social support
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Other Outcomes (3)
NYHA Functional Classification
Data will be collected prior to the commencement of the programme (baseline), at 6 weeks, 3 months and again at 6 months from baseline
Unplanned Health Service Use
Data will be collected at 6 weeks, 3 months and 6 months from baseline after the study intervention
Semi-structured Interview-Process Evaluation
6 months from baseline after participants complete the study
Study Arms (3)
Intervention group A
EXPERIMENTALa 6-week nurse-led, home-based self-management psychosocial education programme (HOM-HEMP)
Intervention group B
EXPERIMENTALHOM-HEMP with the smartphone app.
control group
ACTIVE COMPARATORParticipants will receive the standard care provided by the hospital. It consists of all nursing, medical, and follow-up services as needed.
Interventions
a 6-week nurse-led, home-based self-management psychosocial education programme comprising of a specifically developed HF education and self-management toolkit, three biweekly home visits by the research nurse.
a 6-week nurse-led, home-based self-management psychosocial education programme comprising of a specifically developed HF education and self-management toolkit, three biweekly home visits by the research nurse. In addition, participants will receive a smartphone app. The smartphone will be used to monitor their health data (such as weight, and blood pressure). The data will be synchronized to a web-connected portal on a remote server. The research nurse would be able to access your data through the web-connected portal and provide consultation through scheduled tele or video conference.
standard care provided by the hospital. It consists of all nursing, medical, and follow-up services as needed.
Eligibility Criteria
You may qualify if:
- Clinically diagnosed with HF
- years or older, which is the legal age to give consent in Singapore
- able to comprehend Chinese or English;
- possess and able to use smart mobile phone (e.g. Samsung Galaxy, iPhone) in their daily lives, and
- able to be followed up at home after hospital discharge.
You may not qualify if:
- have unstable angina, resting tachycardia (\>120 beats/minute), or severe arterial hypertension;
- have a terminal illness other than HF, e.g. end-stage renal failure, cancer, severe pulmonary disease;
- have psychiatric or cognitive impairment that will affect patient's understanding of the study intervention and/or nature of the study
- are bed-bound or wheelchair-bound that will affect patient's ability to perform self-care
- No internet access at home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University of Singapore
Singapore, Singapore
Related Publications (1)
Jiang Y, Koh KWL, Ramachandran HJ, Nguyen HD, Lim S, Tay YK, Shorey S, Wang W. The effectiveness of a nurse-led home-based heart failure self-management programme (the HOM-HEMP) for patients with chronic heart failure: A three-arm stratified randomized controlled trial. Int J Nurs Stud. 2021 Oct;122:104026. doi: 10.1016/j.ijnurstu.2021.104026. Epub 2021 Jun 30.
PMID: 34271265DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenru Wang, PhD
National University of Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 30, 2017
First Posted
April 11, 2017
Study Start
June 1, 2018
Primary Completion
February 28, 2020
Study Completion
February 28, 2020
Last Updated
March 15, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share